TTIPF
THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. (TTIPF)
$44
About THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. (TTIPF)
Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company was founded in 2018 and is headquartered in Toronto, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.52
52 Week Low
$0.41
Market cap
19.5M
Dividend yield
0.00%
Volume
5
Avg. volume
450
P/E ratio
-6.32
THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.52
52 Week Low
$0.41
Market cap
19.5M
Dividend yield
0.00%
Volume
5
Avg. volume
450
P/E ratio
-6.32